The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Antibiotic Resistance in India: Drivers and Opportunities for Action
Open accessAbstract
Antibiotic Resistance and Use in IndiaAntibiotic resistance is a global public health threat [1], but nowhere is it as stark as in India [2].The crude infectious disease mortality rate in India today is 416.75 per 100,000 persons (author calculations based on World Bank data and the Global Burden of Disease, 1990 [1,2]) and is twice the rate prevailing in the United States when antibiotics were introduced (roughly 200 per 100,000 persons) [3].A mix of poor public health systems and hospital infection, high rates of infectious disease, inexpensive antibiotics, and rising incomes is coming together to increase prevalence of resistant pathogens and is increasing the burden of untreatable neonatal sepsis and health-care-associated infections [4]. Summary Points• Antibiotic use is a major driver of resistance.In 2010, India was the world's largest consumer of antibiotics for human health.• Access to antibiotics is rising, which portends well for the large proportion of India's population that has thus far had poor access to these life-saving drugs.• The convergence of factors such as poor public health infrastructure, rising incomes, a high burden of disease, and cheap, unregulated sales of antibiotics has created ideal conditions for a rapid rise in resistant infections in India.• Over-the-counter, nonprescription sales of carbapenems in India are among the highest in the world and contribute to growing carbapenem resistance among Gram-negative organisms.• Improving regulation of drug production and sales, better managing physician compensation, and encouraging behavior change among doctors and patients are of immediate priority.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
Self-citationGlobal trends in antimicrobial use in food animals
Van Boeckel, T. P., Brower, C., Gilbert, M., Grenfell, B. T., Levin, S. A., Robinson, T. P., Teillant, A., & Laxminarayan, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503141112 · Cited by 3,973
Self-citationGlobal Spread of Carbapenemase-producing Enterobacteriaceae
Nordmann, P., Naas, T., & Poirel, L. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110655 · Cited by 2,378
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
Van Boeckel, T. P., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B. T., Levin, S. A., & Laxminarayan, R. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70780-7 · Cited by 2,280
Self-citationAccess to effective antimicrobials: a worldwide challenge
Laxminarayan, R., Matsoso, P., Pant, S., Brower, C., Røttingen, J.-A., Klugman, K., & Davies, S. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00474-2 · Cited by 1,465
Self-citationTrends in Infectious Disease Mortality in the United States During the 20th Century
Armstrong, G. L. (1999) · JAMA · doi:10.1001/jama.281.1.61 · Cited by 875
The state of the World's Antibiotics 2015.
Gelbrand, H., Miller-Petrie, M. K., Pant, S., Gandra, S., Levinson, J. A., Barter, D., White, A. M., Laxminarayan, R., Ganguly, N., Kariuki, S., et al. (2015) · Cited by 582
Self-citationHuttner, B., Goossens, H., Verheij, T., & Harbarth, S. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70305-6 · Cited by 574
Rationalizing antibiotic use to limit antibiotic resistance in India.
Ganguly, N. K., Arora, N. K., Chandy, S. J., Fairoze, M. N., Gill, J. P. S., Gupta, U., Hossain, S., Joglekar, S. J., Joshi, P. C., Kakkar, M., et al. (2011) · PubMed Central · Cited by 250
Self-citationRutgersson, C., Fick, J., Marathe, N., Kristiansson, E., Janzon, A., Angelin, M., Johansson, A., Shouche, Y., Flach, C.-F., & Larsson, D. G. J. (2014) · Environmental Science & Technology · doi:10.1021/es501452a · Cited by 192
Cited by
Manyi-Loh, C., Mamphweli, S., Meyer, E., & Okoh, A. (2018) · Molecules · doi:10.3390/molecules23040795 · Cited by 1,808
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide
Piano, S., Singh, V., Caraceni, P., Maiwall, R., Alessandria, C., Fernandez, J., Soares, E. C., Kim, D. J., Kim, S. E., Marino, M., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.005 · Cited by 516
Singh, R., Singh, A. P., Kumar, S., Giri, B. S., & Kim, K.-H. (2019) · Journal of Cleaner Production · doi:10.1016/j.jclepro.2019.06.243 · Cited by 471
Magnano San Lio, R., Favara, G., Maugeri, A., Barchitta, M., & Agodi, A. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20031681 · Cited by 440
Mangla, D., Annu, Sharma, A., & Ikram, S. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.127946 · Cited by 437
Metadata
- Authors
- Laxminarayan, R., & Chaudhury, R. R.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-03-02
- Volume
- 13
- Issue
- 3
- Pages
- e1001974
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2290464731
- Cited by
- 545
- References
- 20
- FWCI
- 36.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antibiotic Resistance in India: Drivers and Opportunities for Action. https://app.cochat.ai/papers/10.1371/journal.pmed.1001974
- The paper
- Laxminarayan, R., & Chaudhury, R. R. (2016). Antibiotic Resistance in India: Drivers and Opportunities for Action. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1001974
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.